MMA
Miracle Mile Advisors Portfolio holdings
AUM
$5.95B
1-Year Return
12.06%
This Quarter Return
+0.11%
1 Year Return
+12.06%
3 Year Return
+43.73%
5 Year Return
+61.49%
10 Year Return
+132.7%
AUM
$4.93B
AUM Growth
+$611M
(+14%)
Cap. Flow
+$660M
Cap. Flow
% of AUM
13.38%
Top 10 Holdings %
Top 10 Hldgs %
34.85%
Holding
677
New
149
Increased
277
Reduced
161
Closed
46
Top Buys
| 1 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
$91.3M |
| 2 |
Apple
AAPL
|
$47.3M |
| 3 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
$29.4M |
| 4 |
Microsoft
MSFT
|
$26.5M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$22.6M |
Top Sells
| 1 |
iShares MSCI Japan ETF
EWJ
|
$33.8M |
| 2 |
Energy Select Sector SPDR Fund
XLE
|
$22.8M |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
$14.5M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
$10.4M |
| 5 |
iMGP DBi Managed Futures Strategy ETF
DBMF
|
$5.91M |
Sector Composition
| 1 | Technology | 10.58% |
| 2 | Financials | 3.74% |
| 3 | Consumer Discretionary | 3.74% |
| 4 | Communication Services | 3.02% |
| 5 | Industrials | 2.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Acuity Brands
AYI
$10.4B
| $202K | ﹤0.01% |
+690
| New | +$202K |
|
602
Idexx Laboratories
IDXX
$51.4B
| $201K | ﹤0.01% |
+487
| New | +$201K |
|
603
Progressive
PGR
$143B
| $201K | ﹤0.01% |
+839
| New | +$201K |
|
|
ACCD
604
DELISTED
Accolade, Inc. Common Stock
ACCD
| $196K | ﹤0.01% |
57,427
| – | – |
|
|
ROIC
605
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $194K | ﹤0.01% |
11,200
| – | – |
|
606
NSTS Bancorp
NSTS
$62.7M
| $171K | ﹤0.01% |
14,500
| – | – |
|
607
Lyft
LYFT
$6.91B
| $166K | ﹤0.01% |
12,864
+1,277
| +11% | +$16.5K |
|
608
PIMCO Corporate & Income Opportunity Fund
PTY
$2.67B
| $151K | ﹤0.01% |
+10,487
| New | +$151K |
|
|
CRT
609
Cross Timbers Royalty Trust
CRT
$52.2M
| $149K | ﹤0.01% |
+15,000
| New | +$149K |
|
610
Roivant Sciences
ROIV
$8.82B
| $148K | ﹤0.01% |
+12,500
| New | +$148K |
|
611
Snap
SNAP
$12.4B
| $144K | ﹤0.01% |
13,408
-8,250
| -38% | -$88.9K |
|
612
Grab
GRAB
$21B
| $143K | ﹤0.01% |
30,317
| – | – |
|
613
Canadian Solar
CSIQ
$748M
| $133K | ﹤0.01% |
+12,000
| New | +$133K |
|
614
AGNC Investment
AGNC
$10.8B
| $131K | ﹤0.01% |
14,268
| – | – |
|
615
Altimmune
ALT
$334M
| $123K | ﹤0.01% |
17,000
| – | – |
|
|
SILV
616
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $108K | ﹤0.01% |
11,922
| – | – |
|
617
WisdomTree
WT
$1.98B
| $107K | ﹤0.01% |
10,151
+27
| +0.3% | +$283 |
|
618
Vale
VALE
$44.4B
| $97.6K | ﹤0.01% |
+11,000
| New | +$97.6K |
|
619
First Majestic Silver
AG
$4.47B
| $88.4K | ﹤0.01% |
16,108
+1,108
| +7% | +$6.08K |
|
620
Forge Global Holdings
FRGE
$233M
| $80.7K | ﹤0.01% |
5,780
+3,113
| +117% | +$43.5K |
|
621
Lionsgate Studios Corp.
LION
$1.78B
| $76K | ﹤0.01% |
+10,000
| New | +$76K |
|
622
Fortuna Silver Mines
FSM
$2.35B
| $64.4K | ﹤0.01% |
15,000
| – | – |
|
623
Genelux
GNLX
$127M
| $59K | ﹤0.01% |
25,000
-15,000
| -38% | -$35.4K |
|
624
Verrica Pharmaceuticals
VRCA
$48.3M
| $58.8K | ﹤0.01% |
8,400
| – | – |
|
|
NAGE
625
Niagen Bioscience, Inc. Common Stock
NAGE
$750M
| $53.1K | ﹤0.01% |
10,000
| – | – |
|